Quick Answer
AbCellera Biologics Inc. reported Total Assets of $1.36 billion for fiscal year 2025.
AbCellera Biologics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.36B | -0.3% |
| 2024 | $1.36B | -8.6% |
| 2023 | $1.49B | -3.4% |
| 2022 | $1.54B | +16.9% |
| 2021 | $1.32B | +31.1% |
| 2020 | $1.01B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.36B | -2.6% | -3.3% |
| June 30, 2025 | $1.40B | -0.7% | +4.3% |
| March 31, 2025 | $1.34B | -8.1% | -1.2% |
| December 31, 2024 | $1.36B | -8.6% | -2.3% |
| September 30, 2024 | $1.39B | -7.9% | -1.4% |
| June 30, 2024 | $1.41B | -8.1% | -3.5% |
| March 31, 2024 | $1.46B | -2.3% | -1.7% |
| December 31, 2023 | $1.49B | -3.4% | -1.6% |
- AbCellera Biologics Inc. showed a decrease of -0.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, AbCellera Biologics Inc.’s total assets has grown by 34.9% (from $1.01 billion to $1.36 billion).
- The most recent figure is from AbCellera Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: